NDC Pharmacologic Class N0000020000 Receptor Tyrosine Kinase Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0069-0145Inlyta AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0151Inlyta AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-8140Xalkori CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-8141Xalkori CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0078-0698Rydapt RydaptCapsule, Liquid FilledOralNovartis Pharmaceuticals CorporationHuman Prescription Drug
62856-704Lenvima LenvatinibCapsuleOralEisai Inc.Human Prescription Drug
62856-708Lenvima LenvatinibCapsuleOralEisai Inc.Human Prescription Drug
62856-710Lenvima LenvatinibCapsuleOralEisai Inc.Human Prescription Drug
62856-712Lenvima LenvatinibCapsuleOralEisai Inc.Human Prescription Drug
62856-720Lenvima LenvatinibCapsuleOralEisai Inc.Human Prescription Drug
63539-026Inlyta AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-044Inlyta AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug

There are 12 NDC products with the pharmacologic class Receptor Tyrosine Kinase Inhibitors [MoA].